Barclays
SWBI icon

Barclays’s Smith & Wesson SWBI Stock Holding History

Barclays’s Portfolio SWBI Stock Details SWBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-36,948
Closed -$236K – 6198
2020
Q1 		$236K Buy
36,948
+24,719
+202% +$175K ﹤0.01% 4160
2019
Q4 		$87K Buy
12,229
+11,839
+3,036% +$72.2K ﹤0.01% 5541
2019
Q3 		$2K Sell
390
-13,921
-97% -$84K ﹤0.01% 6549
2019
Q2 		$99K Buy
14,311
+5,594
+64% +$39.6K ﹤0.01% 5702
2019
Q1 		$63K Sell
8,717
-33,175
-79% -$301K ﹤0.01% 5709
2018
Q4 		$414K Sell
41,892
-26,020
-38% -$270K ﹤0.01% 3976
2018
Q3 		$811K Buy
67,912
+18,994
+39% +$172K ﹤0.01% 3828
2018
Q2 		$452K Sell
48,918
-4,163
-8% -$37.4K ﹤0.01% 4046
2018
Q1 		$421K Sell
53,081
-59,195
-53% -$498K ﹤0.01% 4140
2017
Q4 		$1.11M Sell
112,276
-11,449
-9% -$124K ﹤0.01% 3018
2017
Q3 		$1.45M Buy
123,725
+14,831
+14% +$209K ﹤0.01% 2649
2017
Q2 		$1.85M Buy
108,894
+80,012
+277% +$1.38M ﹤0.01% 2329
2017
Q1 		$440K Sell
28,882
-95,754
-77% -$1.46M ﹤0.01% 3528
2016
Q4 		$2.02M Sell
124,636
-40,071
-24% -$740K ﹤0.01% 2112
2016
Q3 		$3.37M Buy
164,707
+58,936
+56% +$1.29M ﹤0.01% 1586
2016
Q2 		$2.21M Buy
105,771
+71,685
+210% +$1.28M ﹤0.01% 1929
2016
Q1 		$681K Sell
34,086
-23,678
-41% -$441K ﹤0.01% 2863
2015
Q4 		$932K Buy
57,764
+13,400
+30% +$197K ﹤0.01% 2679
2015
Q3 		$546K Sell
44,364
-31,484
-42% -$411K ﹤0.01% 3277
2015
Q2 		$933K Buy
75,848
+49,308
+186% +$569K ﹤0.01% 2936
2015
Q1 		$245K Sell
26,540
-7,156
-21% -$68.4K ﹤0.01% 4182
2014
Q4 		$233K Sell
33,696
-5,334
-14% -$40K ﹤0.01% 4519
2014
Q3 		$270K Sell
39,030
-27,191
-41% -$253K ﹤0.01% 4474
2014
Q2 		$713K Sell
66,221
-11,969
-15% -$141K ﹤0.01% 3648
2014
Q1 		$841K Buy
78,190
+19,905
+34% +$205K ﹤0.01% 3427
2013
Q4 		$582K Sell
58,285
-133,222
-70% -$1.19M ﹤0.01% 3946
2013
Q3 		$1.47M Buy
191,507
+73,766
+63% +$638K ﹤0.01% 2924
2013
Q2 		$903K Buy
+117,741
New +$820K ﹤0.01% 3510

Other funds holding SWBI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Barclays's SWBI Position: Q2 2026 in Review

Barclays reduced its Smith & Wesson (SWBI) stake by 21% in Q2 2026, selling an estimated $50.4K and leaving 12,701 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #3751.

Barclays first reported a position in SWBI in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.25M in Q3 2016. 199 funds tracked by Wall St. Rank hold SWBI as of Q2 2026.

  • Barclays held 12,701 shares of Smith & Wesson worth $191K as of Q2 2026.
  • Barclays sold 3,354 Smith & Wesson shares in Q2 2026, an estimated $50.4K.
  • Smith & Wesson made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3751 holding.
  • Barclays first reported a position in Smith & Wesson in Q2 2013 and has held it in 46 quarters since.
  • Barclays's Smith & Wesson position peaked at $5.25M in Q3 2016.
  • 199 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.